- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06123598
Effects of Mental Practice and Therapeutic Exercise in Mild Smokers
Effects of Mental Practice and Therapeutic Exercise in Mild Smokers: a Randomized Controlled Trial
The goal of this clinical trial is to learn about the effects who would add mental practice based on action observation to a therapeutic exercise program in young mild smokers.
The main question it aims to answer is whether the observation of actions prior to the implementation of a therapeutic exercise program improves the response to it on respiratory, strength and muscle function variables.
Participants will be assigned to one of 2 study groups:
G1) Therapeutic exercise plus action observation training (n=20) G2) Therapeutic exercise plus sham action observation training (n=20)
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Valencia, Spain, 46010
- Universitat de València
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- >18 years old
- Had a pack per year index of <5 (mild smoking index).
Exclusion Criteria:
Those who presented:
- a respiratory pathology,
- cardiac, systematic, or metabolic disease,
- history of recent surgery,
- vertebral fracture,
- or osteoarticular disorders of the spine area.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Action observation plus exercise
Therapeutic exercise plus action observation training
|
Participants make an observation of actions related to the training they are going to perform before each session.
Subsequently, they perform the therapeutic exercise program of 6 sessions in a period of 2 weeks.
|
|
Sham Comparator: Sham observation plus exercise
Therapeutic exercise plus sham action observation training
|
Participants make a sham observation before each session.
Subsequently, they perform the therapeutic exercise program of 6 sessions in a period of 2 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory strength
Time Frame: Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)
|
Maximal respiratory pressures (in H2O centimeters)
|
Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spirometric parameters
Time Frame: Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)
|
Forced expiratory volume in the first second FEV1 (in liters/second) and forced expiratory volume FVC (In liters/second) obtained from a spirometry
|
Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)
|
|
Physical function
Time Frame: Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)
|
5 times sit-to-stand test (in seconds)
|
Before the start of the program, in the middle of the program (1 week) and at the end of the program (2 weeks)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2023-FIS-2731776-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smokers
-
Philip Morris Products S.A.CompletedSmokers | Never SmokersUnited States
-
Universitätsmedizin MannheimCompletedHealthy Subjects | Non-smokers | Smokers
-
Kaohsiung Veterans General Hospital.CompletedCurrent Smokers | Past Smokers | Never SmokersTaiwan
-
Helsinn Healthcare SACelerionCompletedHealthy Volunteers | Non-smokers | Moderate to Heavy SmokersUnited States
-
MTI UniversityCompleted
-
IRCCS San RaffaeleCompleted
-
A. Eden EvinsCompleted
-
Nikki Nollen, PhD, MACompleted
-
Muğla Sıtkı Koçman UniversityCompleted
Clinical Trials on Therapeutic exercise program plus action observation training
-
University of ValenciaActive, not recruiting
-
University of ValenciaCompletedMotor Imagery | Therapeutic Exercise | Action ObservationSpain
-
University of ValenciaCompletedMotor Imagery | Therapeutic Exercise | Action ObservationSpain
-
Riphah International UniversityNot yet recruiting
-
University of AlcalaRecruitingCerebral Palsy | Physical Therapy | Telehealth | Therapeutic EducationSpain
-
Universidad Autonoma de MadridUnknown
-
Universidad Autonoma de MadridCompletedAnalgesia | ExerciseSpain
-
Bahçeşehir UniversityNot yet recruitingNon-specific Low Back PainTurkey (Türkiye)
-
University of PatrasGeneral University Hospital of Patras; Andreas Mentzelopoulos FoundationRecruitingMild Cognitive Impairment | Walking | Cognition | BalanceGreece
-
Istituto Clinico HumanitasNot yet recruiting